In another study, esaxerenone treatment was associated with a reduction in the urine albumin-to-creatinine ratio (UACR) in patients with type 2 diabetes and albuminuria (NCT02345057, unpublished data). This evidence concerns the gene ALB and type 2 diabetes mellitus.